. Author manuscript; available in PMC: 2016 Apr 1.

Published in final edited form as: J Consult Clin Psychol. 2015 Mar 2;83(2):382–386. doi: 10.1037/a0038849

Table 3.

Percent with no OBE episodes at post-treatment (i.e., OBE cessation) with 95% confidence interval by gender, length of treatment and baseline EDE shape/weight concerns.

		Baseline EDE shape/weight concerns
Gender	Treatment length	≤ 3.7	> 3.7
Male	12 or 16 weeks	57% (48%, 66%)	23% (4%, 42%)
	20 or 24 weeks	53% (39%, 67%)	57% (29%, 86%)
Female	12 or 16 weeks	35% (20%, 51%)	31% (13%, 48%)
	20 or 24 weeks	59% (35%, 82%)	54% (40%, 68%)

Note: All cells in the table represent sample sizes of 22 or more. EDE shape/weight concerns was split at the sample median of 3.7.